International Business Machines (IBM)
6
0
0
3
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 6 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 3 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (6)
MyoMobile Study: App-based Activity Coaching in Patients with Heart Failure and Preserved Ejection Fraction
Role: collaborator
COVID-19-Related Opioid Treatment Policy Evaluation
Role: collaborator
Optimizing Patient Usability Experience for Chronic Care
Role: collaborator
Developing Models for Fatigue Monitoring in Obstetrics and Gyne- Cology Residents Using Wearables
Role: collaborator
Teledi@Log - Tele-rehabilitation of Heart Patients
Role: collaborator
The Clinical and Economic Impact of Pharmacogenomic Testing for Tamoxifen Metabolism in Postmenopausal Women Receiving Tamoxifen for Prevention of Recurrent Breast Cancer
Role: collaborator
All 6 trials loaded